The global digital therapeutics market was valued at $1,751 million in 2017 and is expected to reach $7,833 million by 2025, registering a CAGR of 20.5% during the forecast period. Digital therapeutics is a type of treatment option, which utilizes online health technologies and digital devices to treat numerous medical conditions and help maintain health discipline.
Increase in adoption of smartphones & tablets coupled with rise in utilization of healthcare apps is the major factor that drives the growth of the global digital therapeutics market. In addition, increasing need to control healthcare costs supplements the market growth. However, lack of awareness regarding the availability of smartphone applications, especially in the developing countries, acts a major deterrent to the market growth. Conversely, high growth potential in the developing markets is expected to offer significant opportunities for the players operating in this market.
The global digital therapeutics market is segmented into application, product, sales channel, and region. Based on application, the market is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. On the basis of product, it is classified into software and devices. By sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, the business - to - business (B2B) segment is categorized into employers, healthcare providers, and others. Depending on business-to-consumers, the market is fragmented into patients and caregivers. Regionally, it is analyzed across North America, Europe, Asia - Pacific, and LAMEA.
Key benefits for Digital Therapeutics Market :
The study provides an in-depth analysis of the global digital therapeutics market along with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2017 to 2025 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.
Digital Therapeutics Key market segments :
By Application
Diabetes
Obesity
Cardiovascular Disease (CVD)
Central Nervous System (CNS) Disease
Respiratory Disease
Smoking Cessation
Gastrointestinal Disorder (GID)
Others
By Product
Software
Device
By Sales Channel
Business-to-business (B2B)
Employer
Healthcare Provider
Others
Business-to-consumer (B2C)
Patient
Caregiver
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Saudi Arabia
South Africa
Rest of LAMEA
'
CHAPTER 1. INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top Winning Strategies
3.2.3. Top Player Positioning, 2017
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in adoption of smartphone and tablets coupled with healthcare apps
3.4.1.2. Growth in need to control healthcare costs
3.4.1.3. Rise in incidence of chronic diseases
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding digital therapeutics in developing countries
3.4.2.2. Patient data privacy concerns
3.4.3. Opportunity
3.4.3.1. Emerging markets offer significant growth opportunities
CHAPTER 4: DIGITAL THERAPEUTICS MARKET, BY APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Diabetes
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Obesity
4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Cardiovascular diseases
4.4.1. Key market trends and growth opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
4.5. Central nervous system (cns) diseases
4.5.1. Key market trends and growth opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Gastrointestinal disorder
4.6.1. Key market trends and growth opportunities
4.6.2. Market size and forecast
4.6.3. Market analysis, by country
4.7. Respiratory diseases
4.7.1. Key market trends and growth opportunities
4.7.2. Market size and forecast
4.7.3. Market analysis, by country
4.8. Smoking cessation
4.8.1. Key market trends and growth opportunities
4.8.2. Market size and forecast
4.8.3. Market analysis, by country
4.9. Others
4.9.1. Key market trends and growth opportunities
4.9.2. Market size and forecast
4.9.3. Market analysis, by country
CHAPTER 5: DIGITAL THERAPEUTICS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Software
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Devices
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
CHAPTER 6: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Business-To-Business (b2b)
6.2.1. Market size and forecast, by type
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Employer
6.2.4.1. Market size and forecast
6.2.5. Healthcare Providers
6.2.5.1. Market size and forecast
6.2.6. Others
6.2.6.1. Market size and forecast
6.3. Business-to-consumers
6.3.1. Market size and forecast, by type
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Patients
6.3.4.1. Market size and forecast
6.3.5. Caregivers
6.3.5.1. Market size and forecast
CHAPTER 7: DIGITAL THERAPEUTICS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North america
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America digital therapeutics market, by country
7.2.2.1. U.S. digital therapeutics market by application
7.2.2.2. U.S digital therapeutics market by product type
7.2.2.3. U.S. digital therapeutics market by sales channel
7.2.2.4. Canada digital therapeutics market by application
7.2.2.5. Canada digital therapeutics market by product type
7.2.2.6. Canada digital therapeutics market by sales channel
7.2.2.7. Mexico digital therapeutics market by application
7.2.2.8. Mexico digital therapeutics market by product type
7.2.2.9. Mexico digital therapeutics market by sales channel
7.2.3. North America digital therapeutics market, by application
7.2.4. North America digital therapeutics market, by product type
7.2.5. North America digital therapeutics market, by sales channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe digital therapeutics market, by country
7.3.2.1. UK digital therapeutics market by application
7.3.2.2. UK digital therapeutics market by product type
7.3.2.3. UK digital therapeutics market by sales channel
7.3.2.4. Germany digital therapeutics market by application
7.3.2.5. Germany digital therapeutics market by product type
7.3.2.6. Germany digital therapeutics market by sales channel
7.3.2.7. France digital therapeutics market by application
7.3.2.8. France digital therapeutics market by product type
7.3.2.9. France digital therapeutics market by sales channel
7.3.2.10. Italy digital therapeutics market by application
7.3.2.11. Italy digital therapeutics market by product type
7.3.2.12. Italy digital therapeutics market by sales channel
7.3.2.13. Spain digital therapeutics market by application
7.3.2.14. Spain digital therapeutics market by product type
7.3.2.15. Spain digital therapeutics market by sales channel
7.3.2.16. Rest of Europe digital therapeutics market by application
7.3.2.17. Rest of Europe digital therapeutics market by product type
7.3.2.18. Rest of Europe digital therapeutics market by sales channel
7.3.3. Europe digital therapeutics market, by application
7.3.4. Europe digital therapeutics market, by product type
7.3.5. Europe digital therapeutics market, by sales channel
7.4. Asia-pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific digital therapeutics market, by country
7.4.2.1. Japan digital therapeutics market by application
7.4.2.2. Japan digital therapeutics market by product type
7.4.2.3. Japan digital therapeutics market by sales channel
7.4.2.4. China digital therapeutics market by application
7.4.2.5. China digital therapeutics market by product type
7.4.2.6. China digital therapeutics market by sales channel
7.4.2.7. Australia digital therapeutics market by application
7.4.2.8. Australia digital therapeutics market by product type
7.4.2.9. Australia digital therapeutics market by sales channel
7.4.2.10. India digital therapeutics market by application
7.4.2.11. India digital therapeutics market by product type
7.4.2.12. India digital therapeutics market by sales channel
7.4.2.13. South Korea digital therapeutics market by application
7.4.2.14. South Korea digital therapeutics market by product type
7.4.2.15. South Korea digital therapeutics market by sales channel
7.4.2.16. Rest of Asia-Pacific digital therapeutics market by application
7.4.2.17. Rest of Asia-Pacific digital therapeutics market by product type
7.4.2.18. Rest of Asia-Pacific digital therapeutics market by sales channel
7.4.3. Asia-Pacific digital therapeutics market, by application
7.4.4. Asia-Pacific digital therapeutics market, by product type
7.4.5. Asia-Pacific digital therapeutics market, by sales channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA digital therapeutics market, by country
7.5.2.1. Brazil digital therapeutics market by application
7.5.2.2. Brazil digital therapeutics market by product type
7.5.2.3. Brazil digital therapeutics market by sales channel
7.5.2.4. Turkey digital therapeutics market by application
7.5.2.5. Turkey digital therapeutics market by product type
7.5.2.6. Turkey digital therapeutics market by sales channel
7.5.2.7. Saudi Arabia digital therapeutics market by application
7.5.2.8. Saudi Arabia digital therapeutics market by product type
7.5.2.9. Saudi Arabia digital therapeutics market by sales channel
7.5.2.10. South Africa digital therapeutics market by application
7.5.2.11. South Africa digital therapeutics market by product type
7.5.2.12. South Africa digital therapeutics market by sales channel
7.5.2.13. Rest of LAMEA digital therapeutics market by application
7.5.2.14. Rest of LAMEA digital therapeutics market by product type
7.5.2.15. Rest of LAMEA digital therapeutics market by sales channel
7.5.3. LAMEA digital therapeutics market, by application
7.5.4. LAMEA digital therapeutics market, by product type
7.5.5. LAMEA digital therapeutics market, by sales channel
CHAPTER 8: COMPANY PROFILES
8.1. PROTEUS DIGITAL HEALTH, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. OMADA HEALTH, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. WELLDOC, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Key strategic moves and developments
8.4. 2 MORROW INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. LIVONGO HEALTH
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Key strategic moves and developments
8.6. PROPELLER HEALTH
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. TWINE HEALTH, INC. (FITBIT INC.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. CANARY HEALTH, INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. NOOM INC.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. MEDTRONIC PLC
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
TABLE 01. GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 02. DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 20172025 ($MILLION)
TABLE 03. DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 20172025 ($MILLION)
TABLE 04. DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 05. DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 06. SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
TABLE 07. DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 20172025 ($MILLION)
TABLE 08. DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 09. DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 20172025 ($MILLION)
TABLE 10. DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 20172025 ($MILLION)
TABLE 12. DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 20172025 ($MILLION)
TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 20172025 ($MILLION)
TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 16. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)
TABLE 17. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 20172025 ($MILLION)
TABLE 18. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 20172025 ($MILLION)
TABLE 19. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 20172025 ($MILLION)
TABLE 20. GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 21. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 22. U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 23. U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 24. U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 25. CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 26. CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 28. MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 31. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 32. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 33. NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 34. EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 35. UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 36. UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 37. UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 38. GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 39. GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 40. GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 41. FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 42. FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 43. FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 44. ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 45. ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 46. ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 47. SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 48. SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 49. SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 50. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 51. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 52. REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 53. EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 54. EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 55. EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 56. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 57. JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 58. JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 59. JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 60. CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 61. CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 62. CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 63. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 64. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 65. AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 66. INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 67. INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 68. INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 69. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 70. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 71. SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 75. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 76. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 77. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 78. LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 79. BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 80. BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 81. BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 82. TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 83. TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 84. TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 85. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 86. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 87. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 88. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 89. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 90. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 91. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 92. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 93. REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 94. LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2017-2025 ($MILLION)
TABLE 95. LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 96. LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 97. PROTEUS: COMPANY SNAPSHOT
TABLE 98. PROTEUS: PRODUCT PORTFOLIO
TABLE 99. OMADA: COMPANY SNAPSHOT
TABLE 100. WELLDOC: COMPANY SNAPSHOT
TABLE 101. 2MORROW: COMPANY SNAPSHOT
TABLE 102. LIVONGO: COMPANY SNAPSHOT
TABLE 103. LIVONGO: PRODUCT PORTFOLIO
TABLE 104. PROPELLER: COMPANY SNAPSHOT
TABLE 105. TWINE: COMPANY SNAPSHOT
TABLE 106. CANARY: COMPANY SNAPSHOT
TABLE 107. CANARY: PRODUCT PORTFOLIO
TABLE 108. NOOM: COMPANY SNAPSHOT
TABLE 109. MEDTRONIC: COMPANY SNAPSHOT
TABLE 110. MEDTRONIC: OPERATING SEGMENTS
TABLE 111. MEDTRONIC: PRODUCT PORTFOLIO
FIGURE 01. DIGITAL THERAPEUTICSS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN DIGITAL THERAPEUTICSS MARKET, 2017
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2018*
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH BARGAINING POWER OF BUYERS
FIGURE 09. LOW THREAT OF SUBSTITUTION
FIGURE 10. MODERATE THREAT OF NEW ENTRANT
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13. DIGITAL THERAPEUTICS MARKET BY APPLICATION
FIGURE 14. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES , BY COUNTRY, 2017 & 2025, 2023 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 ($MILLION)
FIGURE 22. DIGITAL THERAPEUTICS MARKET, BY PRODUCT
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY, 2017 & 2024 (%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY, 2017 & 2024 (%)
FIGURE 25. DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL
FIGURE 26. COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2017-2025 ($MILLION)
FIGURE 27. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER, 20172025 ($MILLION)
FIGURE 28. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 20172025 ($MILLION)
FIGURE 29. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS, 20172025 ($MILLION)
FIGURE 30. COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2017-2025 ($MILLION)
FIGURE 31. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS, 20172025 ($MILLION)
FIGURE 32. DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS, 20172025 ($MILLION)
FIGURE 33. MEDTRONIC, 20152017 ($MILLION)
FIGURE 34. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 35. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
